Connection

Peter Pickkers to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Peter Pickkers has written about Antibodies, Monoclonal, Humanized.
Peter Pickkers
Connection Strength
0.512
Antibodies, Monoclonal, Humanized
  1. Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients. Crit Care. 2021 08 05; 25(1):281.
    View in: PubMed
    Score: 0.194
  2. Effects of the Humanized Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) on Vascular Barrier Function and Survival in Rodent Models of Systemic Inflammation and Sepsis. Shock. 2018 12; 50(6):648-654.
    View in: PubMed
    Score: 0.161
  3. Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects. Br J Clin Pharmacol. 2018 09; 84(9):2129-2141.
    View in: PubMed
    Score: 0.157
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.